Immune Response Antibody Response Vaccine Development Vaccine Efficacy Immune System Antibodies Vaccines Vaccination Regulatory T Cells Inflammation Cytokines Immune System Disorders Vaccine Research Autoimmune Diseases T Cells Immunosuppression Tumor Immunology Immunotherapy Viral Infections Innate Immunity Clinical Trials Neutrophils Allergic Conditions Type 2 Inflammation Allergic Reactions White Blood Cells Transplant Rejection Cancer Immunotherapy Transplantation Live Vaccines Tumor Microenvironment Immune Cells Tumor Antigens Combination Therapies T-lymphocytes Organ Transplants Inflammatory Diseases IgG Autoantibodies Cellular Immunity Immune Disorders Antiviral Response Influenza Viruses Chronic Inflammatory Conditions Organ Rejection Hypoimmune Cells Immunreaktion IgE-mediated Allergies Antibody Therapy Adaptive Immunity Vaccine Safety Infectious Disease Modeling Gut Health Therapeutics Ageing Cancer Vaccine Types Transplant Immunology Compatibility Testing Autoimmune Disorders Immune Responses Genetic Mutations Primary Immunodeficiency Diseases Vaccine Effectiveness Immunological Memory T Cell Function Thymus Protein-based Vaccines Immunotherapy Strategies Interleukins Bacterial Therapies Virus Strains Influenza Vaccine Response Memory B Cells Immunization Antivenom Research Gut Microbiome Immune Evasion B-cells T Cell Activation Th2 Diseases Live Attenuated Vaccines Immune-inflammatory diseases Adaptive Immune Response Immunomodulation T-cell Therapy Mast Cells Drug Mechanisms Autoimmunity
The move expands Sanofi’s push into T‑cell engagers for B‑cell diseases.
